Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1

Status

Completed 4

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 3Observational 1

Sponsor

Conditions

Arthritis, Rheumatoid 19Spondylitis, Ankylosing 6Psoriasis 4Colitis, Ulcerative 4Crohn Disease 3Inflammatory Bowel Diseases 2Uveal Melanoma 1Thyroid Carcinoma, Anaplastic 1Spondylarthritis 1Sarcoidosis 1Recurrence 1Plaque Psoriasis 1Osteoarthritis 1Nephrotic Syndrome 1Nephrosis, Lipoid 1Mucopolysaccharidosis VI 1Mucopolysaccharidosis II 1Mucopolysaccharidosis I 1Mucopolysaccharidoses 1Melanoma 1Macular dystrophy, corneal type 1 1Kidney Diseases 1Joint Diseases 1Inflammation 1Infections 1Hidradenitis Suppurativa 1Healthy Adult Male 1Healthy 1Glomerulosclerosis, Focal Segmental 1Dupuytren Contracture 1

Interventions

tofacitinib 7Etanercept 7Methotrexate 4Adalimumab 4deucravacitinib 3secukinumab 2apremilast 2Nivolumab 2sotrastaurin 1sodium luminolate 1purine 1ixekizumab 1fumaric acid 1calcipotriene 1cabozantinib 1baricitinib 1abrocitinib 1Vitamin D 1Vaccines 1Sulfasalazine 1Standard of Care 1Specimen Handling 1Saline Solution 1Practice Guidelines as Topic 1Platinum Compounds 1Methods 1Mesalamine 1Mercaptopurine 1Ipilimumab 1Interviews as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Psoriasis × Adalimumab × Clear all
NCT02762955 2021-09-08

CALYPSO

Biocad

Phase 3 Completed
344 enrolled

Psoriasis

NCT02196701 2018-03-19

CLEAR

AbbVie

Phase 3 Completed
46 enrolled 27 charts

Psoriasis

NCT00932113 2017-08-31

MOA

Tufts Medical Center

Phase 4 Completed
33 enrolled 11 charts

Psoriasis

NCT02376478 2015-03-03

On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection

Medical University of Vienna

Completed
222 enrolled

Psoriasis, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡